Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Certara Inc
(NQ:
CERT
)
11.39
-0.07 (-0.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Certara Inc
< Previous
1
2
3
4
5
Next >
The Latest Analyst Ratings for Certara
August 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
August 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 10, 2023
Via
Benzinga
Looking Into Certara's Return On Capital Employed
May 22, 2023
Via
Benzinga
Analyst Expectations for Certara's Future
April 12, 2023
Via
Benzinga
Expert Ratings for Certara
March 27, 2023
Via
Benzinga
Where Certara Stands With Analysts
March 02, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Certara Reports Second Quarter 2023 Financial Results
August 09, 2023
Provides Update to Full Year 2023 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
July 13, 2023
From
Certara
Via
GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
June 02, 2023
From
Certara
Via
GlobeNewswire
Certara Reports First Quarter 2023 Financial Results
May 08, 2023
Reiterates 2023 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
April 27, 2023
Asserts Certara’s leadership in advancing the development and approval of new drugs for patients
From
Certara
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
April 12, 2023
Via
Benzinga
Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
April 10, 2023
From
Certara
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
April 04, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
April 03, 2023
Via
Benzinga
Are These 3 Small Momentum Stocks Setting Up Big Gains?
March 22, 2023
MINISO, PDF Solutions, and Certara are small stocks with strong price momentum. It’s not unusual for small stocks to show more price momentum than larger peers.
Via
MarketBeat
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
March 16, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 16, 2023
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...
Via
Benzinga
A.I. Coming to Certara’s D360 Scientific Informatics Software
March 09, 2023
New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses.
From
Certara
Via
GlobeNewswire
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
March 07, 2023
Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel drugs in lieu of conducting clinical studies
From
Certara
Via
GlobeNewswire
Macy's, Big Lots, Sprouts Farmers Market And Other Big Stocks Moving Higher On Thursday
March 02, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Certara Reports Fourth Quarter and Full Year 2022 Financial Results
March 01, 2023
Annual Revenue Grows 17% on a Reported Basis and 20% at Constant Currency
From
Certara
Via
GlobeNewswire
Certara Announces Transition Plan for Chief Financial Officer
March 01, 2023
From
Certara
Via
GlobeNewswire
Certara to Participate in the Barclays Global Healthcare Conference
February 27, 2023
From
Certara
Via
GlobeNewswire
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
February 01, 2023
From
Certara
Via
GlobeNewswire
Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation
January 04, 2023
Certara improves software capabilities by expanding into deep learning and data fabric
From
Certara
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
December 08, 2022
Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private Equity
From
Certara
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.